Canada Markets closed

NeuroOne Medical Technologies Corporation (NMTC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.5500-0.2000 (-11.43%)
At close: 01:00PM EST
1.5300 -0.02 (-1.29%)
After hours: 04:58PM EST

NeuroOne Medical Technologies Corporation

7599 Anagram Drive
Eden Prairie, MN 55344
United States
952 426 1383
https://n1mtc.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees11

Key Executives

NameTitlePayExercisedYear Born
Mr. David A. Rosa M.D.Pres, CEO & Director603.45kN/A1964
Mr. Ronald W. McClurgChief Financial Officer294.47kN/A1959
Mr. Steven MertensChief Technology Officer298.97kN/A1963
Mr. Mark ChristiansonCo-Founder, Bus. Devel. Director & Medical Sales LiaisonN/AN/A1967
Mr. Hijaz HarisVP of MarketingN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.

Corporate Governance

NeuroOne Medical Technologies Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.